Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Champions Oncology Inc

CSBR
Current price
11.07 USD +0.03 USD (+0.27%)
Last closed 11.02 USD
ISIN US15870P3073
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 84 961 248 USD
Yield for 12 month +95.24 %
1Y
3Y
5Y
10Y
15Y
CSBR
21.11.2021 - 28.11.2021

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey. Address: One University Plaza, Hackensack, NJ, United States, 07601

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.00 USD

P/E ratio

Dividend Yield

Current Year

+50 155 000 USD

Last Year

+53 870 000 USD

Current Quarter

-14 061 000 USD

Last Quarter

+14 061 000 USD

Current Year

+20 754 000 USD

Last Year

+24 338 000 USD

Current Quarter

-21 133 000 USD

Last Quarter

+6 989 000 USD

Key Figures CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -1 169 000 USD
Operating Margin TTM 9.45 %
PE Ratio
Return On Assets TTM -6.93 %
PEG Ratio
Return On Equity TTM -432.46 %
Wall Street Target Price 8.00 USD
Revenue TTM 51 655 000 USD
Book Value -0.024 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 11.90 %
Dividend Yield
Gross Profit TTM 24 338 000 USD
Earnings per share -0.050 USD
Diluted Eps TTM -0.050 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY -28.60 %
Profit Margin -6.58 %

Dividend Analytics CSBR

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:12
Payout Ratio
Last Split Date 12.08.2015
Dividend Date
Consecutive Years
Consistent Years
Continuous Dividends

Stock Valuation CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 22.88
Enterprise Value Revenue 1.68
Price Sales TTM 1.64
Enterprise Value EBITDA 62.85
Price Book MRQ 126.36

Financials CSBR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CSBR

For 52 weeks

3.60 USD 7.13 USD
50 Day MA 4.48 USD
Shares Short Prior Month 224 452
200 Day MA 4.76 USD
Short Ratio 20.86
Shares Short 217 885
Short Percent 3.96 %